CircNFIX Acts as a miR-212-3p Sponge to Enhance the Malignant Progression of Non-Small Cell Lung Cancer by Up-Regulating ADAM10

• Main Authors: Lu J, Zhu Y, Qin Y, Chen Y
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-10-01
• Series: Cancer Management and Research
• Subjects: nsclc; circnfix; mir-212-3p; adam10; malignant progression
• Online Access: https://www.dovepress.com/circnfix-acts-as-a-mir-212-3p-sponge-to-enhance-the-malignant-progress-peer-reviewed-article-CMAR

Jun Lu,1 Ying Zhu,2 Youfa Qin,3 Yikai Chen1 1SSL Central Hospital of Dongguan City (The Third People’s Hospital of Dongguan City), Dongguan, People’s Republic of China; 2Information Section, SSL Central Hospital of Dongguan City (The Third People’s Hospital of Dongguan City), Dongguan, People’s Republic of China; 3Department of Clinical Pharmacy, SSL Central Hospital of Dongguan City (The Third People’s Hospital of Dongguan City), Dongguan, People’s Republic of ChinaCorrespondence: Jun LuSSL Central Hospital of Dongguan City (The third people’s hospital of Dongguan City), No. 01, Huangzhou Xianglong Road, Shilong Town, Dongguan, Guangdong 523326, People’s Republic of ChinaTel [phone]Email [e-mail]: Non-small cell lung cancer (NSCLC) remains the most commonly diagnosed malignancy and the leading cause of cancer death worldwide. Circular RNAs (circRNAs) have been demonstrated to play critical roles in human carcinogenesis, including NSCLC. However, it is still unclear whether circRNA nuclear factor I X (circNFIX) is implicated in the molecular pathogenesis of NSCLC.Methods: The expression levels of circNFIX, miR-212-3p and a disintegrin and metalloproteinases 10 (ADAM10) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) or Western blot. Cell viability was gauged by the Cell Counting Kit-8 (CCK-8) assay, and cell migration and invasion were determined by transwell assays. Glucose uptake and lactate product were determined using the assay kits. Targeted relationships among circNFIX, miR-212-3p and ADAM10 were verified by dual-luciferase reporter and RNA pulldown assays. Additionally, the xenograft model assays were carried out to analyze the role of circNFIX in tumor growth in vivo.Results: Our data revealed that circNFIX was overexpressed in NSCLC and predicted poor prognosis of NSCLC patients. CircNFIX knockdown suppressed NSCLC cell viability, migration, invasion and glycolysis in vitro and hampered tumor growth in vivo. Mechanistically, CircNFIX acted as a molecular sponge of miR-212-3p, and the repressive effect of circNFIX knockdown on NSCLC cell malignant progression was mediated by miR-212-3p. Moreover, ADAM10 was a direct target of miR-212-3p, and circNFIX influenced ADAM10 expression by sponging miR-212-3p in NSCLC cells. Furthermore, the silencing of ADAM10 hindered NSCLC cell viability, migration, invasion and glycolysis in vitro.Conclusion: Our findings first identified that the knockdown of circNFIX, a highly expressed circRNA in NSCLC, exerted a repressive role in NSCLC malignant progression at least in part through targeting the miR-212-3p/ADAM10 axis, illuminating a novel understanding of circRNA regulation in NSCLC.Keywords: NSCLC, circNFIX, miR-212-3p, ADAM10, malignant progression